Sign inJoin waitlistJoin the waitlist

AS

Amy Sherman

Physician · Dana-Farber Cancer Institute

Credentials: · · · ·

History

Dana-Farber Cancer Institute · Brigham and Women's Hospital
2021–Present

Infectious Disease
Emory University School of Medicine
2018–2020
Internal Medicine
Emory University School of Medicine
2014–2015
George Washington Univ Sch of Med
2010–2014

Research

Treatment of hepatitis C: a systematic review
Systematic review or meta-analysis · JAMA · 2014 · 342 citations
COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva
Journal of Clinical Microbiology · 2020 · 204 citations
Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients
Clinical Infectious Diseases · 2022 · 172 citations

Lindsey Baden
36 papers
NR
Nadine Rouphael
18 papers
Nicolas Issa
15 papers
OL
Ofer Levy
15 papers
MD
Michael Desjardins
12 papers · 10 as a resident
MM
Mark Mulligan
9 papers
SW
Stephen Walsh
9 papers
EA
Evan Anderson
7 papers
Ann Woolley
6 papers
HS
Hana El Sahly
6 papers
JW
Jennifer Whitaker
6 papers
JL
Jessica Little
6 papers · 1 as a fellow

Grants

Defining Vaccine Immunogenicity and Adoptive Transfer in Hematopoietic Stem Cell Transplant Recipients
National Institute of Allergy and Infectious Diseases · K23
Contact PI · $388.8K · Brigham and Women's Hospital
2025–2029

Clinical trials

Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection
Principal investigator · Completed · Phase 2
Amy C. Sherman, MD
2019–2022
Shingrix in Renal Transplant Recipients
Site PI · Recruiting · Phase 3
University of Colorado, Denver
2023–2029